<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35587225</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>23</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>23</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1744-5116</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>60</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Pharmaceutical biology</Title>
          <ISOAbbreviation>Pharm Biol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>1α, 25-Dihydroxyvitamin D3 protects gastric mucosa epithelial cells against <i>Helicobacter pylori</i>-infected apoptosis through a vitamin D receptor-dependent c-Raf/MEK/ERK pathway.</ArticleTitle>
        <Pagination>
          <StartPage>801</StartPage>
          <EndPage>809</EndPage>
          <MedlinePgn>801-809</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/13880209.2022.2058559</ELocationID>
        <Abstract>
          <AbstractText Label="CONTEXT" NlmCategory="UNASSIGNED">Due to the resistance of <i>Helicobacter pylori</i> to antibiotics, it is difficult to eradicate this pathogenic bacterium from the host. The role of 1α, 25-dihydroxyvitamin D3 (1,25-D3) in <i>H. pylori</i>-infected gastric mucosa epithelial cells remains unknown.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">This study investigates the protective property of 1,25-D3 against <i>H. pylori</i>-infected apoptosis in gastric mucosa epithelial cells and its potential molecular mechanisms.</AbstractText>
          <AbstractText Label="MATERIALS AND METHODS" NlmCategory="UNASSIGNED">GES-1 cells were infected with <i>H. pylori</i> SS1 strain (MOI: 100) and treated with 1,25-D3 at 100, 200, and 300 nM for 24 h. Mice were orally gavaged with 10<sup>8</sup> CFUs of <i>H. pylori</i> and 25 µg/kg 1,25-D3 every other day for 1 month. CCK-8, LDH assay, TUNEL assay and western blot were used to determine the effect of 1,25-D3 on <i>H. pylori</i>-induced apoptosis.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="UNASSIGNED"><i>H. pylori</i> infection decreased cell viability to 59.2%, while 100-300 nM 1,25-D3 increased cell viability to 62.2%, 78.4% and 87.1%, respectively. Compared with positive control (4.53-fold), 1,25-D3 reduced caspase-3 activity to 4.49-, 2.88- and 1.49-fold, reduced caspase-6 activity to 2.36-, 1.88- and 1.50-fold, reduced caspase-9 activity to 4.55-, 2.91- and 2.01-fold. 1,25-D3 alters Bcl-2 family, caspase protein expression and c-Raf/MEK/ERK phosphorylation levels <i>in vivo</i> and <i>in vitro</i>. Suppression of 1,25-D3 in apoptosis was reliant on binding to vitamin D receptor. The pharmacological inhibition of c-Raf/MEK/ERK phosphorylation blocked the anti-apoptotic effect of 1,25-D3.</AbstractText>
          <AbstractText Label="DISCUSSION AND CONCLUSION" NlmCategory="UNASSIGNED">1,25-D3 protected gastric mucosa epithelial cells against <i>H. pylori</i>-infected apoptosis through a VDR-dependent c-Raf/MEK/ERK pathway.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Shuai</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Pediatric Department of Yantai Yuhuangding Hospital, Qingdao University, Yantai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wan</LastName>
            <ForeName>Daihong</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Pediatric Department of Yantai Yuhuangding Hospital, Qingdao University, Yantai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhong</LastName>
            <ForeName>Yaoyao</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Pediatric Department of Qingdao Women and Children's Hospital, Qingdao University, Qingdao, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xu</LastName>
            <ForeName>Xiwei</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Pharm Biol</MedlineTA>
        <NlmUniqueID>9812552</NlmUniqueID>
        <ISSNLinking>1388-0209</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D002352">Carrier Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D018167">Receptors, Calcitriol</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.12.2</RegistryNumber>
          <NameOfSubstance UI="D020929">Mitogen-Activated Protein Kinase Kinases</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>PQ6CK8PD0R</RegistryNumber>
          <NameOfSubstance UI="D001205">Ascorbic Acid</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001205" MajorTopicYN="N">Ascorbic Acid</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002352" MajorTopicYN="N">Carrier Proteins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004847" MajorTopicYN="N">Epithelial Cells</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005753" MajorTopicYN="N">Gastric Mucosa</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016481" MajorTopicYN="Y">Helicobacter Infections</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016480" MajorTopicYN="Y">Helicobacter pylori</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020935" MajorTopicYN="N">MAP Kinase Signaling System</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020929" MajorTopicYN="N">Mitogen-Activated Protein Kinase Kinases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018167" MajorTopicYN="N">Receptors, Calcitriol</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Bcl-2 family</Keyword>
        <Keyword MajorTopicYN="N">Cell proliferation</Keyword>
        <Keyword MajorTopicYN="N">caspase</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>19</Day>
          <Hour>9</Hour>
          <Minute>42</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35587225</ArticleId>
        <ArticleId IdType="pmc">PMC9122358</ArticleId>
        <ArticleId IdType="doi">10.1080/13880209.2022.2058559</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Bergogne-Bérézin E.
2000. Treatment and prevention of antibiotic associated diarrhea. Int J Antimicrob Agents. 16(4):801–526.</Citation>
        </Reference>
        <Reference>
          <Citation>Burucoa C, Axon A.. 
2017. Epidemiology of Helicobacter pylori infection. Helicobacter. 22:e12403.</Citation>
        </Reference>
        <Reference>
          <Citation>Camilo V, Sugiyama T, Touati E.. 
2017. Pathogenesis of Helicobacter pylori infection. Helicobacter. 22:e12405.</Citation>
        </Reference>
        <Reference>
          <Citation>Cantorna MT, Snyder L, Lin YD, Yang L.. 
2015. Vitamin D and 1,25(OH)2D regulation of T cells. Nutrients. 7(4):3011–3021.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4425186</ArticleId>
            <ArticleId IdType="pubmed">25912039</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chattopadhyay R, Bhattacharyya A, Crowe SE.. 
2010. Dual regulation by apurinic/apyrimidinic endonuclease-1 inhibits gastric epithelial cell apoptosis during Helicobacter pylori infection. Cancer Res. 70(7):2799–2808.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2848894</ArticleId>
            <ArticleId IdType="pubmed">20332233</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G.. 
2016. Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects. Physiol Rev. 96(1):365–408.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4839493</ArticleId>
            <ArticleId IdType="pubmed">26681795</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Costa AM, Ferreira RM, Pinto-Ribeiro I, Sougleri IS, Oliveira MJ, Carreto L, Santos MA, Sgouras DN, Carneiro F, Leite M, et al. . 
2016. Helicobacter pylori activates matrix metalloproteinase 10 in gastric epithelial cells via EGFR and ERK-mediated pathways. J Infect Dis. 213(11):1767–1776.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26802142</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cover TL, Blaser MJ.. 
1992. Purification and characterization of the vacuolating toxin from Helicobacter pylori. J Biol Chem. 267(15):10570–10575.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1587837</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cover TL, Blaser MJ.. 
2009. Helicobacter pylori in health and disease. Gastroenterology. 136(6):1863–1873.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3644425</ArticleId>
            <ArticleId IdType="pubmed">19457415</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crabtree JE, Taylor JD, Wyatt JI, Heatley RV, Shallcross TM, Tompkins DS, Rathbone BJ.. 
1991. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet. 338(8763):332–335.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1677696</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deuster E, Jeschke U, Ye Y, Mahner S, Czogalla B.. 
2017. Vitamin D and VDR in gynecological cancers-a systematic review. Int J Mol Sci. 18:2328.</Citation>
        </Reference>
        <Reference>
          <Citation>Dunn BE, Vakil NB, Schneider BG, Miller MM, Zitzer JB, Peutz T, Phadnis SH.. 
1997. Localization of Helicobacter pylori urease and heat shock protein in human gastric biopsies. Infect Immun. 65(4):1181–1188.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC175115</ArticleId>
            <ArticleId IdType="pubmed">9119449</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gu H.
2017. Role of flagella in the pathogenesis of Helicobacter pylori. Curr Microbiol. 74(7):863–869.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5447363</ArticleId>
            <ArticleId IdType="pubmed">28444418</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guo L, Chen W, Zhu H, Chen Y, Wan X, Yang N, Xu S, Yu C, Chen L.. 
2014. Helicobacter pylori induces increased expression of the vitamin d receptor in immune responses. Helicobacter. 19:37–47.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24188043</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Han S, Li T, Ellis E, Strom S, Chiang JY.. 
2010. A novel bile acid-activated vitamin D receptor signaling in human hepatocytes. Mol Endocrinol. 24(6):1151–1164.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2875805</ArticleId>
            <ArticleId IdType="pubmed">20371703</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hu W, Zhang L, Li MX, Shen J, Liu XD, Xiao ZG, Wu DL, Ho IHT, Wu JCY, Cheung CKY, et al. . 
2019. Vitamin D3 activates the autolysosomal degradation function against Helicobacter pylori through the PDIA3 receptor in gastric epithelial cells. Autophagy. 15(4):707–725.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6526874</ArticleId>
            <ArticleId IdType="pubmed">30612517</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee YC, Chiang TH, Chou CK, Tu YK, Liao WC, Wu MS, Graham DY.. 
2016. Association between Helicobacter pylori eradication and gastric cancer incidence: A systematic review and meta-analysis. Gastroenterology. 150(5):1113–1124.e1115.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26836587</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moss SF.
1998. Helicobacter pylori and apoptosis. Yale J Biol Med. 71(2):53–61.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2578891</ArticleId>
            <ArticleId IdType="pubmed">10378350</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O'Connor A, Liou JM, Gisbert JP, O'Morain C.. 
2019. Review: Treatment of Helicobacter pylori infection 2019. Helicobacter. 24 (Suppl 1):e12640.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31486235</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pierzchalski P, Pytko-Polonczyk J, Jaworek J, Konturek SJ, Gonciarz M.. 
2009. Only live Helicobacter pylori is capable of caspase-3 dependent apoptosis induction in gastric mucosa epithelial cells. J Physiol Pharmacol. 60(4):119–128.</Citation>
        </Reference>
        <Reference>
          <Citation>Valdivielso JM, Fernandez E.. 
2006. Vitamin D receptor polymorphisms and diseases. Clin Chim Acta. 371(1-2):1–12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16563362</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Westblom TU.
1997. Molecular diagnosis of Helicobacter pylori. Immunol Invest. 26(1-2):163–174.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9037621</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xia HH, Talley NJ.. 
2001. Apoptosis in gastric epithelium induced by Helicobacter pylori infection: implications in gastric carcinogenesis. Am J Gastroenterol. 96(1):16–26.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11197247</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
